PL3133083T3 - Wielostopniowa filtracja końcowa - Google Patents

Wielostopniowa filtracja końcowa

Info

Publication number
PL3133083T3
PL3133083T3 PL16188558T PL16188558T PL3133083T3 PL 3133083 T3 PL3133083 T3 PL 3133083T3 PL 16188558 T PL16188558 T PL 16188558T PL 16188558 T PL16188558 T PL 16188558T PL 3133083 T3 PL3133083 T3 PL 3133083T3
Authority
PL
Poland
Prior art keywords
final filtration
multistep
multistep final
filtration
final
Prior art date
Application number
PL16188558T
Other languages
English (en)
Inventor
Roberto Falkenstein
Klaus Schwendner
Original Assignee
F. Hoffmann-La Roche Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F. Hoffmann-La Roche Ag filed Critical F. Hoffmann-La Roche Ag
Publication of PL3133083T3 publication Critical patent/PL3133083T3/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/06Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies from serum
    • C07K16/065Purification, fragmentation
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14Extraction; Separation; Purification
    • C07K1/16Extraction; Separation; Purification by chromatography
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14Extraction; Separation; Purification
    • C07K1/34Extraction; Separation; Purification by filtration, ultrafiltration or reverse osmosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14Extraction; Separation; Purification
    • C07K1/36Extraction; Separation; Purification by a combination of two or more processes of different types
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2866Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for cytokines, lymphokines, interferons
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/32Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against translation products of oncogenes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oncology (AREA)
  • Analytical Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Water Supply & Treatment (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)
  • Fats And Perfumes (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
PL16188558T 2009-10-01 2010-09-29 Wielostopniowa filtracja końcowa PL3133083T3 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP09012460 2009-10-01
EP16188558.7A EP3133083B1 (en) 2009-10-01 2010-09-29 Multistep final filtration
EP10757795.9A EP2483305B1 (en) 2009-10-01 2010-09-29 Multistep final filtration of immunoglobulin
PCT/EP2010/064487 WO2011039274A1 (en) 2009-10-01 2010-09-29 Multistep final filtration

Publications (1)

Publication Number Publication Date
PL3133083T3 true PL3133083T3 (pl) 2020-09-07

Family

ID=41466840

Family Applications (2)

Application Number Title Priority Date Filing Date
PL10757795T PL2483305T3 (pl) 2009-10-01 2010-09-29 Wieloetapowa końcowa filtracja immunoglobuliny
PL16188558T PL3133083T3 (pl) 2009-10-01 2010-09-29 Wielostopniowa filtracja końcowa

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PL10757795T PL2483305T3 (pl) 2009-10-01 2010-09-29 Wieloetapowa końcowa filtracja immunoglobuliny

Country Status (21)

Country Link
US (4) US20120231506A1 (pl)
EP (3) EP3133083B1 (pl)
JP (1) JP5458183B2 (pl)
KR (3) KR101718301B1 (pl)
CN (3) CN103980346A (pl)
AU (1) AU2010302662B2 (pl)
BR (1) BR112012004054B1 (pl)
CA (1) CA2773674C (pl)
CY (1) CY1118577T1 (pl)
DK (1) DK2483305T3 (pl)
ES (2) ES2787403T3 (pl)
HK (2) HK1200178A1 (pl)
HR (2) HRP20161693T1 (pl)
HU (1) HUE030186T2 (pl)
IL (2) IL217626A (pl)
LT (1) LT2483305T (pl)
MX (1) MX342442B (pl)
PL (2) PL2483305T3 (pl)
PT (1) PT2483305T (pl)
SI (2) SI3133083T1 (pl)
WO (1) WO2011039274A1 (pl)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019183334A1 (en) 2018-03-21 2019-09-26 Waters Technologies Corporation Non-antibody high-affinity-based sample preparation, sorbents, devices and methods
CN111007242A (zh) * 2019-12-20 2020-04-14 苏州和迈精密仪器有限公司 基于多层高分子多孔膜的荧光免疫检测方法、装置及应用

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5643566A (en) 1982-09-23 1997-07-01 Cetus Corporation Formulation processes for lipophilic proteins
US4488961A (en) 1982-09-29 1984-12-18 E. I. Du Pont De Nemours And Company One-way filter unit
US4592848A (en) * 1984-12-11 1986-06-03 Pabst Richard E Flow through filter with backflush clearing capability
CS247484B1 (cs) 1985-04-12 1987-01-15 Eva Hamsikova Způsob přípravy imunoglobulinu proti lidským Iymfocytům
WO1989006692A1 (en) 1988-01-12 1989-07-27 Genentech, Inc. Method of treating tumor cells by inhibiting growth factor receptor function
DE3818860A1 (de) 1988-06-03 1989-12-07 Seitz Filter Werke Filterelement
EP0940468A1 (en) 1991-06-14 1999-09-08 Genentech, Inc. Humanized antibody variable domain
DE4204444C1 (pl) 1992-02-14 1993-05-19 Krankenhausentsorgungs Gmbh, 1000 Berlin, De
PT1516628E (pt) 1995-07-27 2013-09-24 Genentech Inc Formulação de proteína liofilizada isotónica estável
DE69739673D1 (de) 1996-11-27 2009-12-31 Genentech Inc Affinitätsreinigung von Polypeptid-Proteinen auf einer Protein A Matrix
ES2292682T3 (es) 1998-05-06 2008-03-16 Genentech, Inc. Purificacion de anticuerpos mediante cromatografia de intercambio ionico.
US6984494B2 (en) * 2000-08-15 2006-01-10 Genentech, Inc. Analytical method
ATE417858T1 (de) 2002-02-05 2009-01-15 Genentech Inc Proteinaufreinigung
CA2490423A1 (en) * 2002-06-21 2003-12-31 Biogen Idec Inc. Buffered formulations for concentrating antibodies and methods of use thereof
WO2004031385A1 (ja) * 2002-10-04 2004-04-15 Kirin Beer Kabushiki Kaisha ヒト人工染色体(hac)ベクター
EP1614693A4 (en) 2003-03-31 2006-07-19 Kirin Brewery Purification of a human monoclonal antibody and human polyclonal antibody
GB0316560D0 (en) * 2003-07-15 2003-08-20 Chiron Srl Vesicle filtration
US20060034850A1 (en) * 2004-05-27 2006-02-16 Weidanz Jon A Antibodies as T cell receptor mimics, methods of production and uses thereof
JP4970260B2 (ja) * 2004-08-20 2012-07-04 プロメティック バイオサイエンシズ,リミテッド 親和性クロマトグラフィーによるタンパク質の逐次的単離および精製スキーム
US20060051347A1 (en) * 2004-09-09 2006-03-09 Winter Charles M Process for concentration of antibodies and therapeutic products thereof
WO2006054798A1 (ja) * 2004-11-22 2006-05-26 Oxygenix Co., Ltd. 酸素同位体で標識したヘモグロビンを含む生体組織検査薬及びその製造方法
TW200902555A (en) 2005-01-03 2009-01-16 Hoffmann La Roche Antibodies against IL-13 receptor alpha 1 and uses thereof
WO2006096461A2 (en) * 2005-03-08 2006-09-14 Pharmacia & Upjohn Company Llc Composition comprising an antibody against macrophage colony-stimulating factor (m-csf) and a chelating agent
CA2618542A1 (en) 2005-08-09 2007-02-15 Takeda Pharmaceutical Company Limited Prophylactic/therapeutic agent for cancer
CA2666607C (en) * 2006-11-01 2015-02-10 Biogen Idec Ma Inc. Method of isolating biomacromolecules using low ph and divalent cations
AR067536A1 (es) 2007-07-17 2009-10-14 Hoffmann La Roche Metodo para obtener una eritropoyetina mono-pegilada en una forma sustancialmente homogenea
AU2008277886B8 (en) * 2007-07-17 2013-08-01 F. Hoffmann-La Roche Ag Variable tangential flow filtration
WO2009058769A1 (en) 2007-10-30 2009-05-07 Schering Corporation Purification of antibodies containing hydrophobic variants
KR20110079693A (ko) 2008-10-29 2011-07-07 와이어쓰 엘엘씨 단일 도메인 항원 결합 분자의 정제 방법
EP2914612B1 (en) * 2012-10-30 2018-11-14 F.Hoffmann-La Roche Ag Purification of polypeptides using dual stage tangential-flow ultrafiltration

Also Published As

Publication number Publication date
BR112012004054A2 (pt) 2020-08-11
KR101653471B1 (ko) 2016-09-01
CA2773674A1 (en) 2011-04-07
KR101718301B1 (ko) 2017-03-20
WO2011039274A1 (en) 2011-04-07
CN103980346A (zh) 2014-08-13
EP3133083A1 (en) 2017-02-22
ES2604103T3 (es) 2017-03-03
JP5458183B2 (ja) 2014-04-02
KR101508044B1 (ko) 2015-04-07
KR20140091763A (ko) 2014-07-22
KR20120053522A (ko) 2012-05-25
CN102574913A (zh) 2012-07-11
IL255658A (en) 2018-01-31
HUE030186T2 (en) 2017-04-28
JP2013505733A (ja) 2013-02-21
DK2483305T3 (en) 2016-10-24
US20200291097A1 (en) 2020-09-17
US11891430B2 (en) 2024-02-06
HRP20200588T1 (hr) 2020-07-10
AU2010302662B2 (en) 2015-11-26
US20180009878A1 (en) 2018-01-11
MX342442B (es) 2016-09-29
HK1200178A1 (en) 2015-07-31
US20120231506A1 (en) 2012-09-13
EP2483305B1 (en) 2016-09-21
KR20160104739A (ko) 2016-09-05
IL217626A (en) 2017-12-31
US20240228589A9 (en) 2024-07-11
CN104610447A (zh) 2015-05-13
LT2483305T (lt) 2016-11-25
BR112012004054B1 (pt) 2021-09-08
SI3133083T1 (sl) 2020-07-31
SI2483305T1 (sl) 2017-01-31
AU2010302662A1 (en) 2012-02-09
CY1118577T1 (el) 2017-07-12
EP3715369A1 (en) 2020-09-30
HRP20161693T1 (hr) 2017-02-24
PL2483305T3 (pl) 2017-03-31
HK1210183A1 (en) 2016-04-15
CA2773674C (en) 2017-08-29
US20240132574A1 (en) 2024-04-25
EP3133083B1 (en) 2020-02-19
PT2483305T (pt) 2016-11-04
MX2012003727A (es) 2012-04-30
EP2483305A1 (en) 2012-08-08
ES2787403T3 (es) 2020-10-16

Similar Documents

Publication Publication Date Title
DK2442650T4 (en) Sublingualt apomorfin
GB201103481D0 (en) No details
GB201016096D0 (en) No details
GB201016097D0 (en) No details
GB0900138D0 (en) Filtering speech
GB0904558D0 (en) Membranes
SI2387446T1 (sl) Kombinacijski filter
GB0922659D0 (en) Factor H
IL216039A0 (en) Concatamers for immunemodulation
GB2468770B (en) Drainage arrangement
GB0916769D0 (en) Water filter
IL255658A (en) Multi-stage final filtering
GB201006421D0 (en) Filter
GB0910950D0 (en) Filtration
HU3614U (en) Water filter
GB0914067D0 (en) Filter means
GB2470588B (en) Drawing aid
GB0900587D0 (en) Can final removal
GB0921794D0 (en) Can final removal
AU4925P (en) Bonscawi Scaevola aemula
AU4240P (en) Tuckerbox xTriticosecale
AU4924P (en) Bonscablue Scaevola aemula
GB0917632D0 (en) Filter
GB0917567D0 (en) Filter
GB0914267D0 (en) Waterpoint filter